406 related articles for article (PubMed ID: 33371312)
41. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
Suades R; Padró T; Alonso R; Mata P; Badimon L
Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
[TBL] [Abstract][Full Text] [Related]
42. Platelet turnover in atherothrombotic disease.
Lordkipanidzé M
Curr Pharm Des; 2012; 18(33):5328-43. PubMed ID: 22724418
[TBL] [Abstract][Full Text] [Related]
43. Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease.
Lisman T
Cell Tissue Res; 2018 Mar; 371(3):567-576. PubMed ID: 29178039
[TBL] [Abstract][Full Text] [Related]
44. The salient role of microRNAs in atherogenesis.
Donaldson CJ; Lao KH; Zeng L
J Mol Cell Cardiol; 2018 Sep; 122():98-113. PubMed ID: 30098321
[TBL] [Abstract][Full Text] [Related]
45. Interaction of platelets with endothelial progenitor cells in the experimental atherosclerosis: Role of transplanted endothelial progenitor cells and platelet microparticles.
Alexandru N; Andrei E; Dragan E; Georgescu A
Biol Cell; 2015 Jun; 107(6):189-204. PubMed ID: 25763472
[TBL] [Abstract][Full Text] [Related]
46. Modulation of platelet and monocyte function by the chemokine fractalkine (CX3 CL1) in cardiovascular disease.
Flierl U; Bauersachs J; Schäfer A
Eur J Clin Invest; 2015 Jun; 45(6):624-33. PubMed ID: 25832902
[TBL] [Abstract][Full Text] [Related]
47. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE
Song Y; Huang Z; Liu X; Pang Z; Chen J; Yang H; Zhang N; Cao Z; Liu M; Cao J; Li C; Yang X; Gong H; Qian J; Ge J
Nanomedicine; 2019 Jan; 15(1):13-24. PubMed ID: 30171903
[TBL] [Abstract][Full Text] [Related]
48. Role of platelets in thrombosis and hemostasis.
Packham MA
Can J Physiol Pharmacol; 1994 Mar; 72(3):278-84. PubMed ID: 8069774
[TBL] [Abstract][Full Text] [Related]
49. Role of platelets in the development of atherosclerosis.
Huo Y; Ley KF
Trends Cardiovasc Med; 2004 Jan; 14(1):18-22. PubMed ID: 14720470
[TBL] [Abstract][Full Text] [Related]
50. [Platelet functions in atherosclerosis].
Matsumoto W; Maruyama I
Nihon Rinsho; 1993 Aug; 51(8):1993-7. PubMed ID: 8411662
[TBL] [Abstract][Full Text] [Related]
51. The role of platelets in atherothrombosis.
Kaplan ZS; Jackson SP
Hematology Am Soc Hematol Educ Program; 2011; 2011():51-61. PubMed ID: 22160012
[TBL] [Abstract][Full Text] [Related]
52. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
[TBL] [Abstract][Full Text] [Related]
53. The role of platelets in the development and complications of atherosclerosis.
Packham MA; Mustard JF
Semin Hematol; 1986 Jan; 23(1):8-26. PubMed ID: 3511536
[TBL] [Abstract][Full Text] [Related]
54. The role of platelets in the recruitment of leukocytes during vascular disease.
Ed Rainger G; Chimen M; Harrison MJ; Yates CM; Harrison P; Watson SP; Lordkipanidzé M; Nash GB
Platelets; 2015; 26(6):507-20. PubMed ID: 26196409
[TBL] [Abstract][Full Text] [Related]
55. Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis.
Wei X; Ying M; Dehaini D; Su Y; Kroll AV; Zhou J; Gao W; Fang RH; Chien S; Zhang L
ACS Nano; 2018 Jan; 12(1):109-116. PubMed ID: 29216423
[TBL] [Abstract][Full Text] [Related]
56. Platelets in sepsis.
Levi M
Hematology; 2005; 10 Suppl 1():129-31. PubMed ID: 16188653
[TBL] [Abstract][Full Text] [Related]
57. Noninvasive Molecular Imaging of Mouse Atherosclerosis.
McAteer MA; Choudhury RP
Methods Mol Biol; 2015; 1339():61-83. PubMed ID: 26445781
[TBL] [Abstract][Full Text] [Related]
58. Diabetes and Hyperglycemia Affect Platelet GPIIIa Expression. Effects on Adhesion Potential of Blood Platelets from Diabetic Patients under In Vitro Flow Conditions.
Przygodzki T; Luzak B; Kassassir H; Mnich E; Boncler M; Siewiera K; Kosmalski M; Szymanski J; Watala C
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370146
[TBL] [Abstract][Full Text] [Related]
59. Anti-inflammatory effects of anti-platelet treatment in atherosclerosis.
Arazi HC; Badimon JJ
Curr Pharm Des; 2012; 18(28):4311-25. PubMed ID: 22236116
[TBL] [Abstract][Full Text] [Related]
60. CXCL4-induced macrophages in human atherosclerosis.
Domschke G; Gleissner CA
Cytokine; 2019 Oct; 122():154141. PubMed ID: 28899579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
